000516 国际医学
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-4.570-9.030-24.575-15.9240.910
总资产报酬率 ROA (%)-1.573-2.997-8.852-6.4620.410
投入资产回报率 ROIC (%)-2.004-3.797-11.094-8.0050.445

边际利润分析
销售毛利率 (%)9.4869.546-6.5661.486-9.210
营业利润率 (%)-9.133-10.005-41.779-31.0180.490
息税前利润/营业总收入 (%)-5.460-5.456-35.114-25.4419.900
净利润/营业总收入 (%)-9.454-10.220-44.093-28.9322.168

收益指标分析
经营活动净收益/利润总额(%)83.811112.12294.05691.820-10,675.258
价值变动净收益/利润总额(%)17.610-15.8085.5547.10110,378.491
营业外收支净额/利润总额(%)-0.1161.1200.6761.467-7.046

偿债能力分析
流动比率 (X)0.3980.4650.6710.6670.744
速动比率 (X)0.3790.4460.6590.6430.726
资产负债率 (%)67.03866.29267.95359.97558.486
带息债务/全部投入资本 (%)56.53855.47659.78449.458--
股东权益/带息债务 (%)76.59579.98067.110101.412102.498
股东权益/负债合计 (%)51.21252.07247.16066.66270.522
利息保障倍数 (X)-1.491-1.170-5.054-4.2121.048

营运能力分析
应收账款周转天数 (天)49.06842.21052.26138.5750.000
存货周转天数 (天)6.2776.3599.5538.8520.000